Reconstitution with Bcr-Abl negative recipient haematopoiesis after allogeneic BMT for CML

被引：0

作者：

Serrano, J ^{[1
]}

Román, J ^{[1
]}

Castillejo, JA ^{[1
]}

Navarro, JA ^{[1
]}

Pascual, A ^{[1
]}

García-Rubio, I ^{[1
]}

Falcón, M ^{[1
]}

Martín, C ^{[1
]}

Sánchez, J ^{[1
]}

Herrera, C ^{[1
]}

Torres, A ^{[1
]}

机构：

[1] Reina Sofia Hosp, Dept Haematol, Cordoba, Spain

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 1998年 / 102卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：318 / 318

页数：1

共 50 条

[41] BCR-ABL targeted therapy in chronic myeloid leukemia (CML). [J].

Goldman, JM ;

Deininger, M ;

Melo, JV .

EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) :515-515

[42] BCR-ABL insufficiency for the transformation of human stem cells into CML [J].

Matioli, GT .

MEDICAL HYPOTHESES, 2002, 59 (05) :588-589

[43] Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML [J].

Brian J Druker .

Oncogene, 2002, 21 :8541-8546

[44] Increase of BCR-ABL/ABL Ratio That Corresponds to BCR-ABL Mutation Detection In Chronic Myeloid Leukemia (CML) Patients Treated by Imatinib (IM) [J].

Tsaur, Grigory ;

Popov, Alexander ;

Ivanova, Anna ;

Yakovleva, Yulia ;

Riger, Tatyana ;

Plekhanova, Olga ;

Ivanets, Yulia ;

Shorikov, Egor ;

Saveliev, Leonid ;

Fechina, Larisa .

FASEB JOURNAL, 2011, 25

[45] BCR-ABL peptide immunisation in chronic myeloid leukaemia (CML) [J].

Clark, RE ;

Knight, K ;

Wang, L ;

Rojas, JM .

EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) :54-54

[46] CML: BCR-ABL Mutation Diagnostics and their Importance for the daily Treatment [J].

不详 .

ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (06) :416-416

[47] BCR-ABL mutant kinetics in CML patients treated with dasatinib [J].

Nicolini, Franck E. ;

Chabane, Kaddour ;

Tigaud, Isabelle ;

Michallet, Mauricette ;

Magaud, Jean-Pierre ;

Hayette, Sandrine .

LEUKEMIA RESEARCH, 2007, 31 (06) :865-868

[48] IN-VITRO PURGING WITH BCR-ABL ANTISENSE OLIGONUCLEOTIDES DOES NOT AFFECT HEMATOPOIETIC RECONSTITUTION AFTER AUTOGRAFT IN PATIENTS WITH CML IN ADVANCED PHASE [J].

DEFABRITIIS, P ;

AVVISATI, G ;

MANCINI, M ;

LISCI, A ;

MONTEFUSCO, E ;

SALA, R ;

CAMPBELL, K ;

GEISER, T ;

AMADORI, S ;

CALABRETTA, B ;

MANDELLI, F .

BLOOD, 1994, 84 (10) :A727-A727

[49] Increasing mixed chimerism in CD15+ cells is associated with relapse in BCR-ABL positive patients after unmanipulated BMT for CML. [J].

Román, J ;

Serrano, J ;

Jiménez, A ;

Castillejo, JA ;

Navarro, JA ;

Garcia-Rubio, I ;

Pascual, A ;

Sánchez, J ;

Maldonado, J ;

Torres, A .

BLOOD, 1998, 92 (10) :346B-346B

[50] DETECTION OF BCR-ABL TRANSCRIPTS BY RT-PCR IN CML PATIENTS AFTER BMT IN COMPARISON WITH THE SIMULTANEOUS IMMUNOPHENOTYPIC AND GENOTYPIC ANALYSIS OF INTERPHASE CELLS [J].

HERNANDEZ, A ;

KOGLER, G ;

HEYLL, A ;

WERNET, P .

EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) :926-926

← 1 2 3 4 5 →